Case Report of Susac Syndrome – A Rare and Challenging Disease

Standard

Case Report of Susac Syndrome – A Rare and Challenging Disease. / van Horn, Laura; van Horn, Noel; Eddy, Mau-Thek; Michels, Peter; Röther, Joachim; Eckert, Bernd; Illies, Till.

In: Clinical Case Reports Journal, Vol. 2, No. 4, 19.10.2021, p. 1-4.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

van Horn, L, van Horn, N, Eddy, M-T, Michels, P, Röther, J, Eckert, B & Illies, T 2021, 'Case Report of Susac Syndrome – A Rare and Challenging Disease', Clinical Case Reports Journal, vol. 2, no. 4, pp. 1-4.

APA

van Horn, L., van Horn, N., Eddy, M-T., Michels, P., Röther, J., Eckert, B., & Illies, T. (2021). Case Report of Susac Syndrome – A Rare and Challenging Disease. Clinical Case Reports Journal, 2(4), 1-4.

Vancouver

van Horn L, van Horn N, Eddy M-T, Michels P, Röther J, Eckert B et al. Case Report of Susac Syndrome – A Rare and Challenging Disease. Clinical Case Reports Journal. 2021 Oct 19;2(4):1-4.

Bibtex

@article{3198384200284d9ab1f862d0d682c4e8,
title = "Case Report of Susac Syndrome – A Rare and Challenging Disease",
abstract = "Objective: Susac Syndrome is a rare disease of unclear pathology and is often misdiagnosed as multiple sclerosis due to its variable appearance. The scope of this case report comprises presenting symptoms, diagnostic measures in terms of different treatment approaches, and possible therapeutic recommendations.Case Presentation: A 30-year-old male patient presenting with holocephalic headaches and visual disturbances is treated with high dose prednisolone, Intravenous Immunoglobulin (IVIG), and mycophenolate mofetil after comprehensive diagnostics. An early reduction of prednisolone led to a reoccurrence of neurological impairment. Nonetheless, an added aggressive and multivalent immunotherapy with mycophenolate mofetil combined with IVIGs and prednisolone prevented further disease progression and even improved neurological symptoms to a stable condition. Patients with encephalopathy of unknown cause may therefore benefit from early ophthalmological assessment and sound threshold audiometry.",
author = "{van Horn}, Laura and {van Horn}, Noel and Mau-Thek Eddy and Peter Michels and Joachim R{\"o}ther and Bernd Eckert and Till Illies",
year = "2021",
month = oct,
day = "19",
language = "English",
volume = "2",
pages = "1--4",
journal = "Clinical Case Reports Journal",
issn = "2767-0007",
number = "4",

}

RIS

TY - JOUR

T1 - Case Report of Susac Syndrome – A Rare and Challenging Disease

AU - van Horn, Laura

AU - van Horn, Noel

AU - Eddy, Mau-Thek

AU - Michels, Peter

AU - Röther, Joachim

AU - Eckert, Bernd

AU - Illies, Till

PY - 2021/10/19

Y1 - 2021/10/19

N2 - Objective: Susac Syndrome is a rare disease of unclear pathology and is often misdiagnosed as multiple sclerosis due to its variable appearance. The scope of this case report comprises presenting symptoms, diagnostic measures in terms of different treatment approaches, and possible therapeutic recommendations.Case Presentation: A 30-year-old male patient presenting with holocephalic headaches and visual disturbances is treated with high dose prednisolone, Intravenous Immunoglobulin (IVIG), and mycophenolate mofetil after comprehensive diagnostics. An early reduction of prednisolone led to a reoccurrence of neurological impairment. Nonetheless, an added aggressive and multivalent immunotherapy with mycophenolate mofetil combined with IVIGs and prednisolone prevented further disease progression and even improved neurological symptoms to a stable condition. Patients with encephalopathy of unknown cause may therefore benefit from early ophthalmological assessment and sound threshold audiometry.

AB - Objective: Susac Syndrome is a rare disease of unclear pathology and is often misdiagnosed as multiple sclerosis due to its variable appearance. The scope of this case report comprises presenting symptoms, diagnostic measures in terms of different treatment approaches, and possible therapeutic recommendations.Case Presentation: A 30-year-old male patient presenting with holocephalic headaches and visual disturbances is treated with high dose prednisolone, Intravenous Immunoglobulin (IVIG), and mycophenolate mofetil after comprehensive diagnostics. An early reduction of prednisolone led to a reoccurrence of neurological impairment. Nonetheless, an added aggressive and multivalent immunotherapy with mycophenolate mofetil combined with IVIGs and prednisolone prevented further disease progression and even improved neurological symptoms to a stable condition. Patients with encephalopathy of unknown cause may therefore benefit from early ophthalmological assessment and sound threshold audiometry.

M3 - SCORING: Journal article

VL - 2

SP - 1

EP - 4

JO - Clinical Case Reports Journal

JF - Clinical Case Reports Journal

SN - 2767-0007

IS - 4

ER -